Shares of INVO Fertility, Inc. (IVF) surged over 60% on Wednesday morning after it reported fourth-quarter and full-year 2024 financial results. Revenues for the fourth quarter increased 22%.
IVF is currently trading at $2.5900, up $0.9800 or 60.8696%, on a huge volume of 56 million shares, above average volume of 116 thousand, on the Nasdaq. The stock opened its trading at $2.1900 after closing Tuesday at $1.6100. The stock has traded between $1.3800 and $17.0400 in the past 52-week period.
Revenues for the quarter were $1.69 million, an increase of 22% compared to $1.38 million last year.
Consolidated clinic revenue from the company's INVO Center in Atlanta, Georgia, and fertility clinic in Madison, Wisconsin, increased 24% to $1.69 million, compared to $1.36 million last year.
Net loss increased to $3.6 million compared to $2.0 million as a result of the addition of NAYA Therapeutics during the period and the corresponding merger costs.
Full-year 2024 revenues surged 116% to $6.53 million from $3.02 million last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.